Skip to main content
Navigate Up
Sign In
 

Axial Spondyloarthritis/Ankylosing Spondylitis Trials


​The Division of Rheumatology strives to understand more about Spondyloarthritis through
research. Please see the list below, which summarizes the studies available to individuals interested in
advancing our understanding and treatment of rheumatic disease.

​Study Name ​Brief Description ​Basic Eligibility Criteria ​Contact
​Program for individuals
with an Elevated Risk
of Spondyloarthritis
(PIERS)
​Long-term research
study of individuals
at risk of spondyloarthritis (SpA). 
This study does not
include a placebo group.
​1) Parent, child, or sibling
(by blood) of
someone with
spondyloarthritis

2) Individuals with SpA
or SpA associated
conditions such as
inflammatory bowel
disease, psoriasis, or
uveitis)
​(303) 724-3539
or by e-mail at
andrew.stahly@ucdenver.edu
 
Please note that study status changes frequently and therefore, a listed study may not be actively
enrolling. Also, the complete list of inclusion and exclusion criteria for a given study is often not listed
due to its length. A visit to determine an individual’s eligibility may be required. A placebo is an inactive
substance or treatment that looks the same as, and is given the same way as, an active drug or
treatment being tested. The effects of the active drug or treatment are compared to the effects of the
placebo.